Everence Capital Management’s Medpace MEDP Stock Holding History

Everence Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$434K	Hold	820	–	–	0.02%	468
2026 Q1	$394K	Hold	820	–	–	0.02%	454
2025 Q4	$461K	Hold	820	–	–	0.03%	418
2025 Q3	$422K	Hold	820	–	–	0.03%	456
2025 Q2	$257K	Hold	820	–	–	0.02%	647
2025 Q1	$250K	Hold	820	–	–	0.02%	650
2024 Q4	$272K	Buy	+820	New	+$278K	0.02%	628
2020 Q3	–	Sell	-5,530	Closed	-$513K	–	716
2020 Q2	$513K	Hold	5,530	–	–	0.06%	285
2020 Q1	$406K	Hold	5,530	–	–	0.06%	291
2019 Q4	$465K	Hold	5,530	–	–	0.07%	304
2019 Q3	$465K	Hold	5,530	–	–	0.08%	287
2019 Q2	$362K	Hold	5,530	–	–	0.06%	363
2019 Q1	$326K	Buy	+5,530	New	+$330K	0.06%	380

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Everence Capital Management's MEDP Position: Q2 2026 in Review

Everence Capital Management held its Medpace (MEDP) position steady in Q2 2026 at 820 shares worth $434K. The position accounts for 0.02% of the portfolio, ranked #468.

Everence Capital Management first reported a position in MEDP in Q1 2019 and has held it in 13 quarters since. The position peaked at $513K in Q2 2020. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Everence Capital Management held 820 shares of Medpace worth $434K as of Q2 2026.
Everence Capital Management left its Medpace share count unchanged in Q2 2026.
Medpace made up 0.02% of Everence Capital Management's portfolio in Q2 2026, its #468 holding.
Everence Capital Management first reported a position in Medpace in Q1 2019 and has held it in 13 quarters since.
Everence Capital Management's Medpace position peaked at $513K in Q2 2020.
697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.